ACQUISITION ANNOUNCEMENT

For a cash purchase price of $30.0 million, Aspire-Lakewood Holdings, Inc. (NASDAQ: ASBP) acquired Dura Control Systems Corp (DCSC), a profitable, global industrial mechatronics leader generating $209.5 million in revenue.

Aspire continues to retain its development-stage pharmaceutical platform and caffeine product line.

$0
FY2025 Revenue
$0
FY2025 Adjusted EBITDA
0
Manufacturing Facilities Across 3 Continents
0+
Years of Operating History

About Dura Control Systems Corp (DCSC)

Dura Safety Critical Vehicle Controls

Dura Control Systems Corp (DCSC) is a global industrial manufacturer of safety-critical vehicle controls—the parts drivers actually touch and use every day. DCSC designs and builds human-machine interface (HMI), actuation, shift, park, pedal, and cable systems for passenger vehicles, commercial vehicles, and off-highway equipment.

The company has more than 110 years of operating history. It began with mechanical control cables and park-brake hardware and now supplies mechatronic systems: electronic and joystick shifters, shift-by-wire actuators, pedal assemblies, electronic park locks, sensors, printed circuit boards, and firmware.

Its products are powertrain-agnostic and used on internal-combustion, hybrid, and battery-electric platforms. Hybrid vehicles typically carry the highest content per vehicle; some EVs require more DCSC content than comparable ICE models because they must include electronic park lock.

DCSC engineers its own products in two technical centers and qualifies them years before production. Replacing a supplier on a safety-critical control system requires re-engineering and re-qualification, which is why the company’s top-ten customer relationships average 28 years. Content runs throughout the vehicle rather than at a single point.

Key facts and figures

  • FY2025 revenue: $209.5 million
  • FY2025 Adjusted EBITDA: $22.3 million (10.6% margin)
  • H1 2026 (six months): $103.9 million revenue, $10.5 million Adjusted EBITDA (10.1% margin)
  • Acquisition: ~$30.0 million cash purchase price; $22.5 million senior secured revolving credit facility; effective July 31, 2026
  • Facilities: 11 manufacturing plants across North America (United States, Mexico), Europe (Germany, France, Czech Republic, Romania, Portugal), and Asia (China, India)
  • Workforce: Approximately 1,700 employees worldwide
  • Intellectual property: 310+ patents; 275+ distinct proprietary parts
  • Customers and platforms: 50+ customers; 250 high-volume vehicle models across 150+ platforms
  • Product families: HMI & Actuation Systems, Safety Systems, Shift Systems, Cable Control Systems, and Industrial Cables & HMI (off-highway)
  • Leadership: Hans Vorstenbosch, Chief Executive Officer; Gregory J. Corona, Chairman
Dura_Logo_large
Dura_Logo_large

The Transaction:
Massive Arbitrage & Value Creation

Asset Acquired: Dura Control Systems Corp (DCSC).
Effective Date: July 31, 2026.
Purchase Price: $30.0 Million Cash.
Credit Facility: Secured $22.5 Million senior revolving credit facility.
Holding Company Strategy: Merges DCSC’s significant revenue and cash flows with the opportunity for expansion into other mobility end markets.

Message from the CEO

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since 1966, when designers at Letraset and James Mosley, the librarian at St Bride Printing Library in London, took a 1914 Cicero translation and scrambled it to make dummy text for Letraset’s Body Type sheets. It has survived not only many decades, but also the leap into electronic typesetting, remaining essentially unchanged. ”
Kraig Higginson
CEO

THIS IS ANOTHER OPTION FOR FACTS/FIGURES VS THE NUMBERS ABOVE

  • FY2025 Revenue: $209.5 Million.

  • FY2025 Adjusted EBITDA: $22.3 Million (10.6% Margin).

  • FY2025 Adjusted EBITDA: $22.3 Million (10.6% Margin).

  • H1 2026 Revenue (6 Months): $103.9 Million (unaudited).
  • H1 2026 Adjusted EBITDA: $10.5 Million (10.1% Margin) (unaudited).

  • Consistency: First-half 2026 performance largely matches the strong 2025 run-rate, proving business resilience.

ABOUT ASPIRE BIO PHARMA – we can maybe add this content from the aspire website?

screenshot to delete

Aspire Biopharma’s technology can be applied to any number of proven drugs and supplements. The list below are just a few examples, but there are undoubtedly many more.

  • Analgesics – global analgesics market (including Opioids) valued approximately $77.0 billion in 2021 and is projected to grow at a 5% CAGR and reach to roughly $103.0 billion by 2028
  • Erectile Dysfunction (ED) – global ED market valued approximately $3.6 billion in 2021 and is projected to grow at a 6.9% CAGR and reach to roughly $5.9 billion by 2028
  • Caffeine Pre-Workout – global pre-workout market value at approximately $19.58 billion in 2024 and growing.